Comprehensive evaluation of the contribution of X chromosome genes to platinum sensitivity

Molecular Cancer Therapeutics

Volumn 10, Issue 3, 2011, Pages 472-480

  Gamazon, Eric R ^a   Im, Hae Kyung ^a   O'Donnell, Peter H ^a   Ziliak, Dana ^a   Stark, Amy L ^a   Cox, Nancy J ^a   Dolan, M Eileen ^a   Huang, Rong Stephanie ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; PLATINUM;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL STRAIN NCI 60; DRUG SENSITIVITY; EUROPE; FEMALE; GENE EXPRESSION; GENOME ANALYSIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NIGERIA; NORTHERN EUROPE; PHARMACOGENOMICS; PRIORITY JOURNAL; RACE DIFFERENCE; SEX CHROMOSOME; UNITED STATES; WESTERN EUROPE; X CHROMOSOME;

CARBOPLATIN; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, X; CISPLATIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; GENES, X-LINKED; GENOME-WIDE ASSOCIATION STUDY; HUMANS;

EID: 79955761331     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-10-0910     Document Type: Article

References (22)

1. Ramaswamy S, Golub TR. DNA microarrays in clinical oncology. J Clin Oncol 2002;20:1932-41. (Pubitemid 34273286)
2. Huang RS, Kistner EO, Bleibel WK, Shukla SJ, Dolan ME. Effect of population and gender on chemotherapeutic agent-induced cytotoxicity. Mol Cancer Ther 2007;6:31-6. (Pubitemid 46206666)
3. Kaiser J. Gender in the pharmacy: does it matter? Science 2005;308:1572.
4. Kim S, Lee S, Cho J, Son S, Choi S, Yun Y, et al. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB. Eur J Pharmacol 2010;631:1-9.
5. Roa W, Chen H, Fulton D, Gulavita S, Shaw A, Th'ng J, et al. X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells. Clin Invest Med 2003;26:231-42.
6. The International HapMap Consortium. A haplotype map of the human genome. Nature 2005;437:1299-320.
7. Huang RS, Duan S, Shukla SJ, Kistner EO, Clark TA, Chen TX, et al. Identification of genetic variants contributing to cisplatin-induced cytotoxicity using a genome-wide approach. Am J Hum Genet 2007;81:427-37. (Pubitemid 47330203)
8. Gamazon ER, Zhang W, Konkashbaev A, Duan S, Kistner EO, Nicolae DL, et al. SCAN: SNP and copy number annotation. Bioinformatics 26;259-62.
9. Zhang W, Duan S, Kistner E, Bleibel W, Huang R, Clark T, et al. Evaluation of genetic variation contributing to differences in gene expression between populations. Am J Hum Genet 2008;82:631-40.
10. Stranger B, Nica A, Forrest M, Dimas A, Bird C, Beazley C, et al. Population genomics of human gene expression. Nat Genet 2007;39:1217-24. (Pubitemid 47482691)
11. Storey JD, Tibshirani R. Statistical significance for genome-wide studies. Proc Natl Acad Sci USA 2003;100:9440-5.
12. Boyd MR, Paull KD. Some practical consideration and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev Des 1995;34:91-109.
13. Weinstein JN. 'Omic' and hypothesis-driven research in the molecular pharmacology of cancer. Curr Opin Pharmacol 2002;2:361-5.
14. Gamazon E, Huang RS, Cox NJ, Dolan ME. Chemotherapeutic drug susceptibility associated SNPs are enriched in expression quantitative trait loci. Proc Natl Acad Sci USA 2010;107:9287-92.
15. O'Donnell PH, Gamazon E, Zhang W, Stark AL, Kistner-Griffin EO, Huang RS, et al. Population differences in platinum toxicity as a means to identify novel genetic susceptibility variants. Pharmacogenet Genom 2010;20:327-37.
16. van Kuilenburg A, Meinsma R, Vreken P, Waterham H, van Gennip A. Identification of a cDNA encoding an isoform of human CTP synthetase. Biochim Biophys Acta 2000;1492:548-52. (Pubitemid 30427376)
17. Stark AL, Zhang W, Mi S, Duan S, O'Donnell PH, Huang RS, et al. Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines. Pharmacogenomics J 2010;10:505-12.
18. Stathakis D, Lee D, Bryant P. DLG3, the gene encoding human neuroendocrine Dlg (NE-Dlg), is located within the 1.8-Mb dystonia-parkinsonism region at Xq13.1. Genomics 1998;49:310-3. (Pubitemid 28240699)
19. Makino K, Kuwahara H, Masuko N, Nishiyama Y, Morisaki T, Sasaki J, et al. Cloning and characterization of NE-dlg: a novel human homolog of the Drosophila discs large (dlg) tumor suppressor protein interacts with the APC protein. Oncogene 1997;14:2425-33. (Pubitemid 27268161)
20. Spielman RS, Bastone LA, Burdick JT, Morley M, Ewens WJ, Cheung VG. Common genetic variants account for differences in gene expression among ethnic groups. Nat Genet 2007;39:226-31. (Pubitemid 46184354)
21. Storey J, Madeoy J, Strout J, Murfel M, Ronald J, Akey J. Gene-expression variation within and among human populations. Am J Hum Genet 2007;80:502-9.
22. Millward MJ, Boyer MJ, Lehnert M, Clarke S, Rischin D, Goh BC, et al. Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients. Ann Oncol 2003;14:449-54. (Pubitemid 36367424)